Isoginkgetin, a Natural Biflavonoid Proteasome Inhibitor, Sensitizes Cancer Cells to Apoptosis via Disruption of Lysosomal Homeostasis and Impaired Protein Clearance

REFERENCES

• Thrower JS, Hoffman L, Rechsteiner M, Pickart CM. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J 19:94–102. https://doi.org/10.1093/emboj/19.1.94.
   PubMed Web of Science ®Google Scholar
• Coux O, Tanaka K, Goldberg AL. 1996. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801–847. https://doi.org/10.1146/annurev.bi.65.070196.004101.
   PubMed Web of Science ®Google Scholar
• Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–380. https://doi.org/10.1016/S0092-8674(00)80929-0.
   PubMed Web of Science ®Google Scholar
• Craiu A, Gaczynska M, Akopian T, Gramm CF, Fenteany G, Goldberg AL, Rock KL. 1997. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem 272:13437–13445. https://doi.org/10.1074/jbc.272.20.13437.
   PubMed Web of Science ®Google Scholar
• DeMarini DJ, Papa FR, Swaminathan S, Ursic D, Rasmussen TP, Culbertson MR, Hochstrasser M. 1995. The yeast SEN3 gene encodes a regulatory subunit of the 26S proteasome complex required for ubiquitin-dependent protein degradation in vivo. Mol Cell Biol 15:6311–6321. https://doi.org/10.1128/MCB.15.11.6311.
   PubMed Web of Science ®Google Scholar
• Ciechanover A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13–21. https://doi.org/10.1016/0092-8674(94)90396-4.
   PubMed Web of Science ®Google Scholar
• Vembar SS, Brodsky JL. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9:944–957. https://doi.org/10.1038/nrm2546.
   PubMed Web of Science ®Google Scholar
• Ihara Y, Morishima-Kawashima M, Nixon R. 2012. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006361. https://doi.org/10.1101/cshperspect.a006361.
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. 2009. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 335:1–32. https://doi.org/10.1007/978-3-642-00302-8_1.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Emr SD. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290:1717–1721. https://doi.org/10.1126/science.290.5497.1717.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131–24145. https://doi.org/10.1074/jbc.M702824200.
   PubMed Web of Science ®Google Scholar
• Lippai M, Low P. 2014. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int 2014:832704. https://doi.org/10.1155/2014/832704.
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Johansen T. 2006. p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2:138–139. https://doi.org/10.4161/auto.2.2.2405.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132–141. https://doi.org/10.1038/ncb2152.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332:1429–1433. https://doi.org/10.1126/science.1204592.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095–1108. https://doi.org/10.1038/emboj.2012.32.
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, Puertollano R. 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:903–914. https://doi.org/10.4161/auto.19653.
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Brady OA, Puertollano R. 2016. TFEB and TFE3 are novel components of the integrated stress response. EMBO J 35:479–495. https://doi.org/10.15252/embj.201593428.
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, Puertollano R. 2014. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 7:ra9. https://doi.org/10.1126/scisignal.2004754.
   PubMed Web of Science ®Google Scholar
• Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio A. 2011. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 20:3852–3866. https://doi.org/10.1093/hmg/ddr306.
   PubMed Web of Science ®Google Scholar
• Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, Chaudhury A, Bajaj L, Bondar VV, Bremner L, Saleem U, Tse DY, Sanagasetti D, Wu SM, Neilson JR, Pereira FA, Pautler RG, Rodney GG, Cooper JD, Sardiello M. 2017. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8:14338. https://doi.org/10.1038/ncomms14338.
   PubMed Web of Science ®Google Scholar
• Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP. 2008. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 9:227–239. https://doi.org/10.2174/138920308784533998.
   PubMed Web of Science ®Google Scholar
• Yoon SO, Shin S, Lee HJ, Chun HK, Chung AS. 2006. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 5:2666–2675. https://doi.org/10.1158/1535-7163.MCT-06-0321.
   PubMed Web of Science ®Google Scholar
• Boswell SA, Snavely A, Landry HM, Churchman LS, Gray JM, Springer M. 2017. Total RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis. Nat Chem Biol 13:501–507. https://doi.org/10.1038/nchembio.2317.
   PubMed Web of Science ®Google Scholar
• Johnston JA, Ward CL, Kopito RR. 1998. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883–1898. https://doi.org/10.1083/jcb.143.7.1883.
   PubMed Web of Science ®Google Scholar
• Cao J, Wang J, Qi W, Miao HH, Wang J, Ge L, DeBose-Boyd RA, Tang JJ, Li BL, Song BL. 2007. Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. Cell Metab 6:115–128. https://doi.org/10.1016/j.cmet.2007.07.002.
   PubMed Web of Science ®Google Scholar
• Erie C, Sacino M, Houle L, Lu ML, Wei J. 2015. Altered lysosomal positioning affects lysosomal functions in a cellular model of Huntington’s disease. Eur J Neurosci 42:1941–1951. https://doi.org/10.1111/ejn.12957.
   PubMed Web of Science ®Google Scholar
• Korolchuk VI, Saiki S, Lichtenberg M, Siddiqi FH, Roberts EA, Imarisio S, Jahreiss L, Sarkar S, Futter M, Menzies FM, O’Kane CJ, Deretic V, Rubinsztein DC. 2011. Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 13:453–460. https://doi.org/10.1038/ncb2204.
   PubMed Web of Science ®Google Scholar
• Van Hoewyk D. 2016. Use of the non-radioactive SUnSET method to detect decreased protein synthesis in proteasome inhibited Arabidopsis roots. Plant Methods 12:20. https://doi.org/10.1186/s13007-016-0120-z.
   PubMed Web of Science ®Google Scholar
• Stewart D, Killeen E, Naquin R, Alam S, Alam J. 2003. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem 278:2396–2402. https://doi.org/10.1074/jbc.M209195200.
   PubMed Web of Science ®Google Scholar
• Nakanishi C, Toi M. 2005. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5:297–309. https://doi.org/10.1038/nrc1588.
   PubMed Web of Science ®Google Scholar
• Steinbrunn T, Stuhmer T, Gattenlohner S, Rosenwald A, Mottok A, Unzicker C, Einsele H, Chatterjee M, Bargou RC. 2011. Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival. Blood 117:1998–2004. https://doi.org/10.1182/blood-2010-05-284422.
   PubMed Web of Science ®Google Scholar
• Chauhan D, Anderson KC. 2003. Mechanisms of cell death and survival in multiple myeloma (MM): therapeutic implications. Apoptosis 8:337–343. https://doi.org/10.1023/A:1024164700094.
   PubMed Web of Science ®Google Scholar
• Anderson KC. 2004. Bortezomib therapy for myeloma. Curr Hematol Rep 3:65.
   Google Scholar
• Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS. 1999. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93:3044–3052.
   PubMed Web of Science ®Google Scholar
• Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC. 1996. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood 87:1104–1112.
   PubMed Web of Science ®Google Scholar
• Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH. 2003. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci U S A 100:9946–9951. https://doi.org/10.1073/pnas.1334037100.
   PubMed Web of Science ®Google Scholar
• Elfrink HL, Zwart R, Baas F, Scheper W. 2013. Inhibition of endoplasmic reticulum associated degradation reduces endoplasmic reticulum stress and alters lysosomal morphology and distribution. Mol Cells 35:291–297. https://doi.org/10.1007/s10059-013-2286-9.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Le Moigne R, Djakovic S, Kumar B, Rice J, Wong S, Wang J, Yao B, Valle E, Kiss von Soly S, Madriaga A, Soriano F, Menon MK, Wu ZY, Kampmann M, Chen Y, Weissman JS, Aftab BT, Yakes FM, Shawver L, Zhou HJ, Wustrow D, Rolfe M. 2015. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 28:653–665. https://doi.org/10.1016/j.ccell.2015.10.002.
   PubMed Web of Science ®Google Scholar
• Wang Q, Shinkre BA, Lee JG, Weniger MA, Liu Y, Chen W, Wiestner A, Trenkle WC, Ye Y. 2010. The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group. PLoS One 5:e15479. https://doi.org/10.1371/journal.pone.0015479.
   Google Scholar
• Santaguida S, Amon A. 2015. Aneuploidy triggers a TFEB-mediated lysosomal stress response. Autophagy 11:2383–2384. https://doi.org/10.1080/15548627.2015.1110670.
   PubMed Web of Science ®Google Scholar
• Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C, Wang W, Gao Q, Xu H, Sandri M, Rizzuto R, De Matteis MA, Ballabio A. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 17:288–299. https://doi.org/10.1038/ncb3114.
   PubMed Web of Science ®Google Scholar
• Kilpatrick K, Zeng Y, Hancock T, Segatori L. 2015. Genetic and chemical activation of TFEB mediates clearance of aggregated alpha-synuclein. PLoS One 10:e0120819. https://doi.org/10.1371/journal.pone.0120819.
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang H, Hao Z, Fu C, Hu Q, Gao F, Ren H, Chen D, Han J, Ying Z, Wang G. 2016. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J 35:121–142. https://doi.org/10.15252/embj.201591998.
   PubMed Web of Science ®Google Scholar
• Pastore N, Blomenkamp K, Annunziata F, Piccolo P, Mithbaokar P, Maria Sepe R, Vetrini F, Palmer D, Ng P, Polishchuk E, Iacobacci S, Polishchuk R, Teckman J, Ballabio A, Brunetti-Pierri N. 2013. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol Med 5:397–412. https://doi.org/10.1002/emmm.201202046.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Matlin AJ, Lowell AM, Moore MJ. 2008. The biflavonoid isoginkgetin is a general inhibitor of pre-mRNA splicing. J Biol Chem 283:33147–33154. https://doi.org/10.1074/jbc.M805556200.
   PubMed Web of Science ®Google Scholar
• Geng F, Wenzel S, Tansey WP. 2012. Ubiquitin and proteasomes in transcription. Annu Rev Biochem 81:177–201. https://doi.org/10.1146/annurev-biochem-052110-120012.
   PubMed Web of Science ®Google Scholar
• Vabulas RM, Hartl FU. 2005. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310:1960–1963. https://doi.org/10.1126/science.1121925.
   PubMed Web of Science ®Google Scholar
• Mizrachy-Schwartz S, Cohen N, Klein S, Kravchenko-Balasha N, Levitzki A. 2010. Amino acid starvation sensitizes cancer cells to proteasome inhibition. IUBMB Life 62:757–763. https://doi.org/10.1002/iub.377.
   PubMed Web of Science ®Google Scholar
• Tsalikis J, Tattoli I, Ling A, Sorbara MT, Croitoru DO, Philpott DJ, Girardin SE. 2015. Intracellular bacterial pathogens trigger the formation of U small nuclear RNA bodies (U bodies) through metabolic stress induction. J Biol Chem 290:20904–20918. https://doi.org/10.1074/jbc.M115.659466.
   PubMed Web of Science ®Google Scholar
• Horibata S, Vo TV, Subramanian V, Thompson PR, Coonrod SA. 2015. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. J Vis Exp 2015:e52727. https://doi.org/10.3791/52727.
   Google Scholar
• Schmidt EK, Clavarino G, Ceppi M, Pierre P. 2009. SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods 6:274–277. https://doi.org/10.1038/nmeth.1314.
   Web of Science ®Google Scholar